A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
about
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic reviewMolecular pathology of non-small cell lung cancer: a practical guide.Improving molecular testing and personalized medicine in non-small-cell lung cancer in OntarioReview of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice.EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinomaNon-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases.Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized MedicineTreatment algorithms for patients with metastatic non-small cell, non-squamous lung cancerChallenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare SystemComparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in TaiwanDiagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRASTreatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line.Personalized choice of maintenance therapies in non-small-cell lung cancerThe importance of multidisciplinary team management of patients with non-small-cell lung cancer.Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncologyImpact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines for EGFR and ALK testing in lung cancer in CanadaComprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.In situ Protein Detection for Companion Diagnostics.Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.New targets in non-small cell lung cancer.Precision treatment for cancer: role of prognostic and predictive markers.Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first, second, and third-line.The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-small Cell Lung Cancer.Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer.Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC).Prognostic and predictive markers for personalized adjuvant therapy for non-small-cell lung cancer patients.Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?Decision support systems for incurable non-small cell lung cancer: a systematic reviewDoes immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.[Molecular pathology of the lungs. New perspectives by next generation sequencing].Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.Predictive Tumor Biomarkers for EGFR Inhibitors
P2860
Q27022535-9EC34C63-1187-4993-BB5C-10052231E8B0Q27690919-AD063FA3-D8C8-4991-87A5-83C694D88E4CQ33611088-2F81C91D-2E3B-4C8D-BA44-B2A1AA93481FQ33757138-B08FFB18-35B9-4431-8B56-731EC32A3F05Q34108365-0FBA6A5B-1A30-421F-9DAD-0084B970A946Q34216371-2BEF4714-555A-46DA-BCFA-3A27E219CF9AQ34219452-A4BD57D9-5C5F-440D-BEEA-39A2A42951A1Q34259692-48C671D9-D152-4A66-AEE7-7D04C8CB668DQ34608597-84A4A56C-2647-43CF-A891-4BD8021EB2D7Q34947842-190253D8-33CD-4C4A-8EC6-9029A2B18EC6Q35934241-31EC9560-CC14-4261-BA66-56CD8117E51FQ36040599-85E00C32-CE94-4D9F-9E22-FBBDE9678B55Q36040606-6D7B745E-162C-4D43-AD98-DFF67140479EQ36040619-66DCC118-0D63-4FAF-8DD6-9DC016E8F846Q36040632-641DBC69-E752-4F6D-AEED-66D1DD54742CQ36040638-A2788D8A-E51E-47B4-BEAD-98C9CA3E540BQ36405628-3AF6B013-1F68-4369-8708-8AFEE77740B1Q37056876-23A38233-A477-4F6D-8AAA-8EC330D8F823Q37109885-FCA6A3D2-4F97-470A-842B-3141B0AA9CD9Q37270405-89C79E69-8B89-4BE8-9B81-A0AA62F13B8EQ38096410-4DBBF270-C3ED-4A7D-9D18-FE1071165337Q38114835-3F437C71-F1BD-49A3-9DE6-5109AF2E96BDQ38179024-93A5490C-6E02-4B12-9A45-05033E5FFB67Q38229049-5843EBE8-E2EB-4BB5-B4AA-6B29B8BB9B87Q38607262-75501F2C-4645-4072-879E-1ED12B89B625Q38792120-24C2AE14-18E6-46C8-8477-A187CB21AB0BQ39012785-858F57DC-8EBB-4877-97DD-C7A0FBB43F0BQ39303306-25564BBB-9EF1-4E28-AD41-A3DA29FADE69Q39309830-229E96DF-5DAE-4664-AA94-D0EDEC817B1DQ42284446-BED57E3E-1428-4394-8054-82EDE658095FQ45276482-BA339D38-073B-46D3-8528-01C3922D6271Q54048311-2239E6F9-AFBB-462C-B92C-8AF3622700DFQ54395887-CB246AC2-D630-48A6-8B1D-A46AB7B168E7Q57896476-084F5424-D271-4201-ADB0-39550D3CE4EF
P2860
A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A systematic review and Canadi ...... of non-small cell lung cancer.
@ast
A systematic review and Canadi ...... of non-small cell lung cancer.
@en
A systematic review and Canadi ...... of non-small cell lung cancer.
@nl
type
label
A systematic review and Canadi ...... of non-small cell lung cancer.
@ast
A systematic review and Canadi ...... of non-small cell lung cancer.
@en
A systematic review and Canadi ...... of non-small cell lung cancer.
@nl
prefLabel
A systematic review and Canadi ...... of non-small cell lung cancer.
@ast
A systematic review and Canadi ...... of non-small cell lung cancer.
@en
A systematic review and Canadi ...... of non-small cell lung cancer.
@nl
P2093
P1476
A systematic review and Canadi ...... of non-small cell lung cancer
@en
P2093
Barb Melosky
Dennis Soulieres
Diana N Ionescu
Frances A Shepherd
Meenakshi Kashyap
Natasha B Leighl
Normand Blais
Peter M Ellis
Phillippe Romeo
Tony Reiman
P304
P356
10.1097/JTO.0B013E318220CB8E
P577
2011-08-01T00:00:00Z